Hints and tips:
Related Special Reports
...Business is so tricky. At least Liberty is apparently trying to make things better....
...Nvidia redesigned some of its most powerful products — the A100 and H100 — to lower their specs and bring them into compliance with those rules in order to continue doing business in China, where it makes...
...What that shows is that big companies have shied away from doing mega deals but smaller acquisitions have gone ahead as they probably posed less of a threat....
...Zin Mar Aung said it was clear China was not satisfied with how Myanmar was doing. “The SAC is not able to bring stability to our country, so if there is no stability, how can China do business?”...
...drugs into the medical supply chain, Opara says....
...“It is not at all clear that Merck is doing anything other than extending its monopoly power over the drug,” Warren said....
...Sentiment is one hell of a drug, and it should come as no surprise that venture capital, which has perfected the art of moving entire markets through its echo-chamber hype, has managed to hype its own rumours...
...doing anything against the law....
...BlackRock, Wells Fargo, Bank of America and State Street were also excluded from doing business with the state, Oklahoma said....
...Nisbet describes it as a “rethink” and says she would like to steer the focus towards artists — “often overlooked in the business of doing everything else”....
...I mean, there is a shared responsibility that says nobody wants to kill the industry, but it needs to make sure that as it moves forward, it’s doing so in a legally defensible way....
...But after the sudden death of last year’s disqualified Derby winner, Medina Spirit, who failed his post-race drug test, it’s a refreshing sign that some stable hands may actually be doing what’s best for...
...Like all large pharma companies, Merck’s business development team maintains a long list of potential targets, ranging from smaller biotechs with exciting but unproven drugs to larger companies with medicines...
...Creditors could miss the stable cash flows generated by the consumer business when the pharma-led business faces challenges from loss of exclusivity from blockbuster drugs, say some critics....
...Regeneron, though, is hardly a mom-and-pop business. It has a market value of $60bn....
...Investors are being asked to forgo about £60m to avoid doing business with a company whose main product kills people. That would be short-sighted and simplistic....
...We will do our best to make the amendment as soon as possible....
...In late July, the US Food and Drug Administration identified the CPAP devices as a Class I recall, the most serious type, having received more than 1,200 complaints and reports of more than 100 injuries....
...BioNTech needed to make money from its first product to plough back into the business....
...“These Chinese criminal networks, who were doing the same sorts of things in China a few years ago, are now being chased overseas, they’re finding space where you have corrupt actors and continue doing the...
...As drug dealers and other shady collectors flood the market, US lawmakers are cracking the whip....
...McKinney added that it would be difficult for J&J to show the adenovirus method “is as good as doing it directly with lipid droplets like Moderna and Pfizer are using in their coronavirus vaccines”....
...The regulatory offensive against the company and some of its affiliates comes as financial supervisors around the world worry that money from illegal drugs, ransomware and other crimes is washing back into...
...“We are doing everything we can.”...
...“In 2009-10, pharma companies were priced as if they were going to go out of business, as if they were never going to have a [new] drug again,” he says....
International Edition